The purpose of this prospective study is to evaluate the efficacy of the ResAppDx software application in diagnosis of pneumonia and other respiratory conditions (bronchiolitis, asthma/reactive airway disease, croup, upper or lower respiratory tract infections) in infants and children. Patient's cough sounds will be recorded using a smartphone and analysed using the ResAppDx software. The ResAppDx diagnosis will be compared to radiologic diagnosis and/or clinical diagnosis. The ResAppDx diagnosis will not be provided to the clinician or patient.
Study Type
OBSERVATIONAL
Enrollment
1,245
Smartphone recordings of the cough sounds of infants and children presenting to a participating site with signs or symptoms of respiratory disease
Massachusetts General Hospital
Boston, Massachusetts, United States
Cleveland Clinic Children's
Cleveland, Ohio, United States
Texas Children's Hospital
Houston, Texas, United States
Diagnosis of pneumonia
Positive percent agreement and negative percent agreement to diagnose and rule out pneumonia as compared with a radiologic diagnosis. Positive percent agreement and negative percent agreement to diagnose and rule out pneumonia as compared with a clinical diagnosis.
Time frame: 6 months
Diagnosis of other childhood respiratory diseases
Positive percent agreement and negative percent agreement to diagnose and rule out: lower respiratory tract involvement, bronchiolitis, asthma/reactive airway disease, upper respiratory tract infection and/or croup, as compared with a clinical diagnosis.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.